Clinical whole exome sequencing in child neurology practice

Whole exome sequencing (WES) represents a significant breakthrough in clinical genetics as a powerful tool for etiological discovery in neurodevelopmental disorders. To better characterize the genetic landscape of neurodevelopmental disorders, we analyzed patients in our pediatric neurogenetics clinic who underwent WES.

[1]  M. King,et al.  Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. , 2009, American journal of human genetics.

[2]  J. Milunsky,et al.  Updates in the genetic evaluation of the child with global developmental delay or intellectual disability. , 2012, Seminars in pediatric neurology.

[3]  H. Ropers,et al.  On the future of genetic risk assessment , 2012, Journal of Community Genetics.

[4]  A. StAteMent.  Points to consider in the clinical application of genomic sequencing , 2012, Genetics in Medicine.

[5]  T. Kleefstra,et al.  Making headway with genetic diagnostics of intellectual disabilities , 2014, Clinical genetics.

[6]  M. Rieder,et al.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.

[7]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[8]  De novo mutations in epileptic encephalopathies , 2013 .

[9]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[10]  A. StAteMent.  Points to consider for informed consent for genome/exome sequencing , 2013, Genetics in Medicine.

[11]  Sophia B. Hufnagel,et al.  Laboratory policies on reporting secondary findings in clinical whole exome sequencing: Initial uptake of the ACMG's recommendations , 2014, American journal of medical genetics. Part A.

[12]  Evan E. Eichler,et al.  A Genotype-First Approach to Defining the Subtypes of a Complex Disease , 2014, Cell.

[13]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[14]  Rena A. Godfrey,et al.  The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases , 2011, Genetics in Medicine.

[15]  Eric M. Morrow,et al.  Using Whole-Exome Sequencing to Identify Inherited Causes of Autism , 2013, Neuron.

[16]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[17]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[18]  B. Levinson,et al.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. , 2003, The New England journal of medicine.

[19]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[20]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[21]  Jonathan A. Bernstein,et al.  Clinical whole-exome sequencing: are we there yet? , 2014, Genetics in Medicine.

[22]  Vineet Bafna,et al.  Exome Sequencing Can Improve Diagnosis and Alter Patient Management , 2012, Science Translational Medicine.

[23]  J. Moeschler.  Genetic evaluation of intellectual disabilities. , 2008, Seminars in pediatric neurology.

[24]  A. Hoischen,et al.  A de novo non-sense mutation in ZBTB18 in a patient with features of the 1q43q44 microdeletion syndrome , 2013, European Journal of Human Genetics.